Simultaneous VEGF-positive and EGFR-negative expression was associated with a lack of complete tumour regression in more than 94% of cases and a 12-fold-decreased odds of response compared with EGFR-positive and VEGF-negative tumours. This evidence concerns the gene EGFR and neoplasm.